Novartis India (BOM:500672) E10: ₹0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500672 Novartis India Ltd BOM:500672
52 GF Score
Price ₹1,668.95
GF Value ₹927.24
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Novartis India E10?

Novartis India BOM:500672 -1.77% 52 E10 is ₹0.00 as of Jun. 2026. GuruFocus rates BOM:500672 with a GF Score™ of 52/100 and a GF Value™ of ₹927.24 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novartis India's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹13.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Novartis India's average E10 Growth Rate was -14.50% per year. During the past 3 years, the average E10 Growth Rate was -0.50% per year. During the past 5 years, the average E10 Growth Rate was -2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Novartis India was 4.00% per year. The lowest was -7.10% per year. And the median was -0.50% per year.

As of today (2026-07-24), Novartis India's current stock price is ₹1668.95. Novartis India's E10 for the quarter that ended in Jun. 2026 was ₹0.00. Novartis India's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Novartis India was 59.29. The lowest was 15.45. And the median was 24.85.


Novartis India  (BOM:500672) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Novartis India was 59.29. The lowest was 15.45. And the median was 24.85.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novartis India E10 Related Terms


Novartis India E10 Historical Data

* Premium members only.

The historical data trend for Novartis India's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis India E10 Chart

Novartis India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.27 28.58 28.06 32.91 28.15

Novartis India Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.82 30.17 28.10 28.15 0.00

BOM:500672 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Novartis India's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis India Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis India's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novartis India's Shiller PE Ratio falls into.


BOM:500672
52GF Score
Novartis India Ltd BOM:500672
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novartis India E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novartis India's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=13.05/166.1454*166.1454
=13.050

Current CPI (Jun. 2026) = 166.1454.

Novartis India Quarterly Data

per share eps CPI Adj_EPS
201609 7.030 105.961 11.023
201612 4.770 105.196 7.534
201703 1.030 105.196 1.627
201706 2.500 107.109 3.878
201709 9.280 109.021 14.142
201712 6.660 109.404 10.114
201803 9.600 109.786 14.528
201806 4.050 111.317 6.045
201809 3.800 115.142 5.483
201812 5.210 115.142 7.518
201903 7.910 118.202 11.118
201906 0.320 120.880 0.440
201909 -2.110 123.175 -2.846
201912 3.130 126.235 4.120
202003 2.740 124.705 3.651
202006 1.780 127.000 2.329
202009 3.050 130.118 3.894
202012 -0.290 130.889 -0.368
202103 3.920 131.771 4.943
202106 2.550 134.084 3.160
202109 2.840 135.847 3.473
202112 2.570 138.161 3.091
202203 -9.470 138.822 -11.334
202206 21.210 142.347 24.756
202209 7.430 144.661 8.533
202212 3.080 145.763 3.511
202303 10.120 146.865 11.449
202306 8.210 150.280 9.077
202309 9.590 151.492 10.518
202312 10.760 152.924 11.690
202403 5.940 153.035 6.449
202406 10.420 155.789 11.113
202409 8.270 157.882 8.703
202412 10.310 158.323 10.819
202503 11.870 157.552 12.517
202506 11.190 159.755 11.638
202509 9.810 162.289 10.043
202512 6.520 163.281 6.634
202603 10.230 164.272 10.347
202606 13.050 166.145 13.050

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹0.00 mean?
Novartis India (BOM:500672) has a E10 of ₹0.00 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Novartis India and its competitors.
Is Novartis India's E10 too high?
Novartis India's current E10 is ₹0.00. Overall, Novartis India has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Novartis India's E10 compare to ZTS and UTHR?
Novartis India's E10 of ₹0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Novartis India and its competitors. Novartis India's current E10 is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis India stock overvalued right now?
Based on GuruFocus' analysis, Novartis India (BOM:500672) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹927.24, compared to a current price of ₹1,668.95 — trading 80% above its estimated fair value. The current E10 is ₹0.00. Novartis India's overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Novartis India (BOM:500672), the current E10 is ₹0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novartis India (BOM:500672) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis India stock appears to be overvalued. The current stock price of ₹1,668.95 is trading 80% above its estimated GF Value™ of ₹927.24. GuruFocus considers Novartis India to be Significantly Overvalued.

Key valuation signals for BOM:500672:

  • E10: ₹0.00
  • GF Value™: ₹927.24 vs. price of ₹1,668.95 (80% above fair value)
  • GF Score™: 52/100 with 7 warning signs

No single metric tells the full story. See the BOM:500672 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novartis India Business Description

Other Exchanges NOVARTIND:India
Address Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company operates in a single business segment, namely Pharmaceutical Business. Its Pharmaceutical business focuses on Bone and Pain, Transplantation Immunology, and Neurosciences.
52GF Score

Get the complete analysis for BOM:500672

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,668.95
Price
₹927.24
GF Value